to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
Return to Top
Search Result Details
Back to Search Results
This page shows the details of why an item matched the keywords from your search.
One or more keywords matched the following items that are connected to
Integrating PET and CT information to improve diagnostic accuracy for lung nodules: A semiautomatic computer-aided method.
Prognostic value of metabolic tumor burden on 18F-FDG PET in nonsurgical patients with non-small cell lung cancer.
Prognostic value of the quantitative metabolic volumetric measurement on 18F-FDG PET/CT in Stage IV nonsurgical small-cell lung cancer.
FDG-PET/CT findings of a metastatic pituitary tumor.
Prognostic value of tumor burden measurement using the number of tumors in non-surgical patients with non-small cell lung cancer.
Interobserver variability among measurements of the maximum and mean standardized uptake values on (18)F-FDG PET/CT and measurements of tumor size on diagnostic CT in patients with pulmonary tumors.
Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Independent prognostic value of whole-body metabolic tumor burden from FDG-PET in non-small cell lung cancer.
Relationship between Overall Survival of Patients with Non-Small Cell Lung Cancer and Whole-Body Metabolic Tumor Burden Seen on Postsurgical Fluorodeoxyglucose PET Images.
Consistency of metabolic tumor volume of non-small-cell lung cancer primary tumor measured using 18F-FDG PET/CT at two different tracer uptake times.
Prognostic value of quantitative PET/CT in patients with a nonsmall cell lung cancer and another primary cancer.
An updated and validated PET/CT volumetric prognostic index for non-small cell lung cancer.
Developing and validating a novel metabolic tumor volume risk stratification system for supplementing non-small cell lung cancer staging.
Developing a PET Volumetric Staging System for NSCLC: a Complement to TNM Staging
Developing a PET Volumetric Staging System for NSCLC: a Complement to TNM Staging.
Developing a clinical and PET/CT volumetric prognostic index for risk assessment and management of NSCLC patients after initial therapy.